Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Richard Jordan
Institution:
University of California San Francisco Medical Center
Observed institution:
University of California San Francisco Medical Center
ORCID:
0000-0002-2558-0537
Observed ORCID:
0000-0002-2558-0537
OpenAlex ID:
A5124997568
Spatial transcriptomics-guided pathology biomarker as a predictor of benefit of adjuvant docetaxel in high-risk localized prostate cancer: NRG/RTOG 0521 (NCT00288080).
2026
·
Md Mamunur Rahaman
, Amritpal Singh
, et al.
·
Journal of Clinical Oncology
·
1
Data from A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
2026
·
Sebastian Medina
, Naoto Tokuyama
, et al.
Supplementary Figure S8 from A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
2026
·
Sebastian Medina
, Naoto Tokuyama
, et al.
Supplementary Figure S13 from A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
2026
·
Sebastian Medina
, Naoto Tokuyama
, et al.
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type